Autologous Stem Cell-Based Tissue Engineered Vascular Grafts
Autologous Stem Cell-Based Tissue Engineered Vascular Grafts
批准号:
8426531
负责人:
David Alan Vorp
金额:
$19.06万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-15 至 2014-12-31
关键词:
AddressAdipose tissueAdultAffectAgeAreaArteriesAutologousBindingBiocompatibleBiocompatible MaterialsBiomechanicsBiomimeticsBlood VesselsBone MarrowBypassCardiovascular DiseasesCellsClinicalCoronary Artery BypassDevelopmentEffectivenessElderlyExhibitsFatty acid glycerol estersFemaleGoalsHarvestHumanImmuneInstitutesLaboratoriesMedicineMesenchymal Stem CellsMethodologyMethodsModelingMuscleNatural regenerationOrgan TransplantationOutcomePatientsPerformancePeripheralProcessRattusRegenerative MedicineRelative (related person)Research PersonnelResourcesScientific SocietiesSecureShapesSolutionsSourceStem cellsTechnologyTestingTissue EngineeringTissuesTranslationsTreatment EfficacyUnited States National Institutes of HealthUrsidae FamilyVascular GraftVascular remodelingVeinsVenousWorkbasecost effectivedensityelastomerichuman adult stem cellhuman stem cellsimmunosuppressedin vivoin vivo Modelinnovationmalenovelpatient populationpreventpublic health relevanceregenerativeresponsescaffoldsexstem cell biologysuccesstherapy development
中文摘要
描述(由申请人提供):由于目前的临床选择不可靠,美国每年进行的近100万例动静脉搭桥、外周动脉搭桥和动静脉搭桥手术都需要一种成功的血管移植。R21提案的总体目标是通过解决实际实施的关键问题和阻碍当前范例成功的限速障碍,开始我们新颖的、自体的、基于干细胞的组织工程血管移植(TEVG)的临床移植过程。考虑到有需要的患者群体中脂肪的分离和可获得性相对容易,这项提议将侧重于脂肪来源干细胞(ADSCs)的使用。在这项提案中将解决以下重要问题:a)从患者的典型单次采集中分离的自体成人ADSC的数量有限。获得成功的TEVG所需的ADSC播种密度下限是多少?B)年龄和性别都被证明影响心血管疾病的发展和治疗效果。使用所有患者的ADSCs的基于干细胞的TEVG是否可行,或者某些因素(例如,男性或女性,超过一定年龄的患者)是否会排除这种疗法?因此,这项为期两年的计划的两个具体目标是:1)评估ADSC种植密度对在老鼠模型中测试的TEVG构建的性能的影响;以及2)评估相同性别的大鼠模型中供者的年龄和性别对基于人类细胞的TEVG构建的体内性能的影响。这项工作的预期结果是成功开发基于人类干细胞的TEVG的重要一步,使其更接近临床翻译。据我们所知,没有其他研究解决了临床实用性的关键问题,比如这里要解决的那些用于开发基于干细胞的人类TEVG的问题。
英文摘要
DESCRIPTION (provided by applicant): There is a significant need for a successful vascular graft for the nearly one million aortocoronary bypass, peripheral arterial bypass, and arterio-venous access graft procedures performed each year in the US, as current clinical options are unreliable. The overall goal of this R21 proposal is to begin the process of clinical translation o our novel, autologous, stem cell-based tissue engineered vascular graft (TEVG) by addressing critical issues of practical implementation and rate-limiting barriers that have prevented current paradigms from being successful. This proposal will focus on use of adipose-derived stem cells (ADSCs), given the relative ease of isolation and availability of fat in the patient population in need. The following important issues/questions will be addressed in this proposal: A) Autologous adult ADSCs isolated in a typical single harvest from a patient are limited in number. What is the lower bound of ADSC seeding density necessary to yield a successful TEVG? B) Age and sex have both been shown to influence cardiovascular disease development and treatment efficacy. Will a stem cell-based TEVG using ADSCs from all patients be feasible, or will certain factors (e.g., male or female sex, patients beyond a certain age) preclude this therapy? Accordingly, the two specific aims of this 2-year proposal are: 1) Assess the effect of ADSC seeding density on the performance of TEVG constructs tested in a rat model; and 2) Assess the effect of donor age and sex in a rat model of the same sex on in-vivo performance of human cell-based TEVG constructs. The expected outcome of this work is an important step toward the successful development of a human stem cell-based TEVG, moving it significantly closer to clinical translation. No other study, to our knowledge, has addressed critical issues of clinical practicality, such as those to be addressed here, for the development of a human, stem cell-based TEVG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomechanics in Regenerative Medicine (BiRM) Training Program
-
批准号:10628407
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2023
-
负责人:David Alan Vorp
-
依托单位:
A Machine Learning-Based Clinical Decision Support Tool to Predict Abdominal Aortic Aneurysm Prognosis Using Existing Longitudinal Data
-
批准号:10331850
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2021
-
负责人:David Alan Vorp
-
依托单位:
A Machine Learning-Based Clinical Decision Support Tool to Predict Abdominal Aortic Aneurysm Prognosis Using Existing Longitudinal Data
-
批准号:10115365
-
项目类别:
-
资助金额:$11.74万
-
财政年份:2021
-
负责人:David Alan Vorp
-
依托单位:
The Role of Fibrinolysis in Tissue Engineered Vascular Grafts for Aged Individuals
-
批准号:9979086
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2020
-
负责人:David Alan Vorp
-
依托单位:
Preclinical optimization and design for manufacturability of immunoregulatory tissue-engineered vascular grafts
-
批准号:10054024
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2020
-
负责人:David Alan Vorp
-
依托单位:
Artificial Stem Cells for Vascular Tissue Engineering
-
批准号:9175164
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2016
-
负责人:David Alan Vorp
-
依托单位:
Artificial Stem Cells for Vascular Tissue Engineering
-
批准号:9276786
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2016
-
负责人:David Alan Vorp
-
依托单位:
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular Graft
-
批准号:9015874
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2016
-
负责人:David Alan Vorp
-
依托单位:
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular Graft
-
批准号:9260065
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2016
-
负责人:David Alan Vorp
-
依托单位:
2011 Summer Bioengineering Conference
-
批准号:8201445
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2011
-
负责人:David Alan Vorp
-
依托单位:
Biomechanical Evaluation of Abdominal Aortic Aneurysm
-
批准号:7822203
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2009
-
负责人:David Alan Vorp
-
依托单位:
Bioengineered Urethral Augmentation
-
批准号:7286848
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2006
-
负责人:David Alan Vorp
-
依托单位:
Bioengineered Urethral Augmentation
-
批准号:7201955
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2006
-
负责人:David Alan Vorp
-
依托单位:
Bioengineering & Biologic Studies of Aneurysm Weakening
-
批准号:7074647
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:David Alan Vorp
-
依托单位:
Bioengineering & Biologic Studies of Aneurysm Weakening
-
批准号:6968396
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2005
-
负责人:David Alan Vorp
-
依托单位:
Bioengineering & Biologic Studies of Aneurysm Weakening
-
批准号:7616820
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2005
-
负责人:David Alan Vorp
-
依托单位:
Bioengineering & Biologic Studies of Aneurysm Weakening
-
批准号:7243501
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2005
-
负责人:David Alan Vorp
-
依托单位:
Bioengineering & Biologic Studies of Aneurysm Weakening
-
批准号:7431718
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2005
-
负责人:David Alan Vorp
-
依托单位:
BIOMECHANICAL EVALUATION OF ABDOMINAL AORTIC ANEURYSM
-
批准号:6698092
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2001
-
负责人:David Alan Vorp
-
依托单位:
Biomechanical Evaluation of Abdominal Aortic Aneurysm
-
批准号:7104089
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2001
-
负责人:David Alan Vorp
-
依托单位:
海外基金